FDA-Approved Anticancer Drug Library

Cat. No.: HY-L122: Library Contents: XLSX PDF SDF

Cancer is the second leading cause of death worldwide and a serious threat to human health. Multiple treatments have been developed for cancer treatment, but new anti-cancer drugs still need to be developed urgently. Approved drugs, have well-characterized bioactivities, safety and bioavailability properties, will dramatically accelerate drug development.

MCE offers a unique collection of 1247 approved drugs with anti-cancer activity, which can be used for discovery of new anti-cancer drugs or as positive compounds used for anti-cancer research.

MCE FDA-Approved Anticancer Drug Library can be supplied as pre-dissolved Solutions or Solid. For pre-dissolved solutions in this library, there are 1207 compounds supplied in 10 mM solution, 31 compounds supplied in 2 mM solution and 9 compounds supplied in 3 mg/mL solution.

For pre-dissolved solutions, 10 mM for compounds with the solubility not lower than 10 mM, 2 mM for compounds with solubility between 2 mM and 10 mM, and 3 mg/mL for compounds with unconfirmed molecular weight and solubility not lower than 3 mg/mL.

Size (Pre-dissolved Solution or Solid)	Price	Stock
30 μL/well Solution 10 mM , 2 mM and 3 mg/mL Pre-dissolved Solution	Get quote	In-stock
50 μL/well Solution 10 mM , 2 mM and 3 mg/mL Pre-dissolved Solution	Get quote	In-stock
100 μL/well Solution 10 mM , 2 mM and 3 mg/mL Pre-dissolved Solution	Get quote	In-stock
2 × 100 μL/well Solution 10 mM , 2 mM and 3 mg/mL Pre-dissolved Solution	Get quote	In-stock

Download Screening Library Catalog

Please contact us at

[email protected]

Publications Citing Use of MCE Compound Libraries

Description
Product Details
Documentation

Description & Advantages	• A unique collection of 1247 approved drugs with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS). • A useful tool for anti-cancer research and drug repurposing. • All compounds have been approved by the FDA, EMA and other countries. • Structurally diverse, bioactive, and cell permeable. • More detailed compound information with structure, IC50, and brief introduction. • NMR and HPLC validated ensure high purity. • All compounds are in stock and continuously updated.
Product Details	Formulation: A collection of 1247 approved anti-cancer drugs supplied as pre-dissolved Solutions or Solid Solution: 1207 compounds supplied in 10 mM solution, 31 compounds supplied in 2 mM solution, 9 compounds supplied in 3 mg/mL solution. Layout: 96-well storage tube or 96-well plate: 1st and 12th column are left empty. 384-well plate: the first two columns and the last two columns are left empty. Compounds with different concentrations or dissolved in different solvents will be put on separate plates. This way of layout may increase the number of plates because there could be three solvents and three concentrations. If you have other requirements, please let us know. Container: 96- or 384-well Plate with Peelable Foil Seal; 96-well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode Storage: In solvent: -80°C 2 years, -20°C 1 year; Powder: -20°C 3 years, 4°C 2 years Shipping: Blue ice
Documentation	XLSX PDF Library Handling Instructions (351 KB)

Your Recently Viewed Products:

Product Name

Salutation

Applicant Name *

Email Address *

Phone Number *

Organization Name *

Department *

Requested quantity *

Country or Region *

Container *

Remarks

FDA-Approved Anticancer Drug Library

Publications Citing Use of MCE Compound Libraries

Description

Product Details

Documentation

Your Recently Viewed Products:

Request for SDF File

Request for SDF File